SCHEMBL3990318

SCHEMBL3990318

COC(=O)Oc1ccc2c(C(=O)c3cc(Cl)ncn3)cn(C)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 6/20 0.35
ALDH1A1 P00352 3/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
POLB P06746 1/20 0.33
LMNA P02545 2/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3989840 0.94 MTNR1A (0.39) NR4A2MTNR1AMTNR1BABCG2
SCHEMBL3995936 0.89 ALDH1A1 (0.44) ALDH1A1HDAC1HDAC2HDAC6HDAC3
SCHEMBL3986985 0.83 ABCG2 (0.47) NR4A2ALDH1A1MTNR1AMTNR1BLMNA
SCHEMBL3992240 0.82 POLB (0.38) NR4A2ALDH1A1POLBLMNACNR2
SCHEMBL3992947 0.82 POLB (0.38) ALDH1A1POLBLMNACNR2MEN1
SCHEMBL3997478 0.80 POLB (0.36) NR4A2ALDH1A1POLBLMNACNR2
SCHEMBL3978572 0.80 PCSK9 (0.40) ALDH1A1POLBLMNAPSEN1PSEN2
SCHEMBL3972624 0.79 POLB (0.55) NR4A2ALDH1A1POLBLMNAMEN1
SCHEMBL4259652 0.78 NR4A2 (0.34) NR4A2ALDH1A1LMNAABCG2MEN1
SCHEMBL4257184 0.78 PCSK9 (0.36) NR4A2ALDH1A1POLBLMNACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2065382-A1 CGRP antagonists Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-06-03 EP disclosed
WO-2009050235-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed